AskNiveshLive·14:52 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to AKUMS

Akums Drugs and Pharmaceuticals Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
1,0561,0241,0181,1601,158
Other income
1827323435
Segment revenue (incl. inter-segment)
1,0561,0241,0181,1601,158
Expenses
1,0069559841,0761,070
Cost of materials consumed
624548553611587
Purchases of stock-in-trade
2021576063
Change in inventories
-413-17711
Employee benefit expense
184176189189199
Finance costs
523232424
Depreciation & amortisation
4037384040
Other expenses
139137141145147
EBITDA
120156127163185
EBIT
8011989123145
Operating profit
629360112117
Exceptional items
8---18-2
Profit Before Tax
759666100121
Tax expense
-7531233240
Deferred tax
-9374521
Net Profit
15065436881
Financial Ratios
Operating Profit Margin
5.86%9.08%5.87%9.66%10.10%
EBITDA Margin
11.33%15.21%12.47%14.04%15.98%
Net Profit Margin
14.20%6.32%4.19%5.84%7.02%
Earnings Per Share (₹)
9.644.152.664.335.53

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.